US Patent Issued to Revolution Medicines on Jan. 20 for "Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5decan-8-yl-5-methylpyrazin-2-yl} methanol, a SHP2 inhibitor" (California Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,807, issued on Jan. 20, was assigned to Revolution Medicines Inc. (Redwood City, Calif.).

"Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5decan-8-yl-5-methylpyrazin-2-yl} methanol, a SHP2 inhibitor" was invented by Shaoling Li (Redwood City, Calif.) and Steven G. Ballmer (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to crystalline solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl}methanol, or a pharmaceutically acceptable salt thereof, the process o...